JP2008526873A - アポトーシス誘発抗腫瘍性銀（ｉ）配位錯体 - Google Patents

アポトーシス誘発抗腫瘍性銀（ｉ）配位錯体 Download PDF

Info

Publication number
JP2008526873A
JP2008526873A JP2007550477A JP2007550477A JP2008526873A JP 2008526873 A JP2008526873 A JP 2008526873A JP 2007550477 A JP2007550477 A JP 2007550477A JP 2007550477 A JP2007550477 A JP 2007550477A JP 2008526873 A JP2008526873 A JP 2008526873A
Authority
JP
Japan
Prior art keywords
acid
silver
chiral
composition
organic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550477A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526873A5 (https=
Inventor
アイ． バターセ，カリーム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2008526873A publication Critical patent/JP2008526873A/ja
Publication of JP2008526873A5 publication Critical patent/JP2008526873A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2007550477A 2005-01-11 2006-01-05 アポトーシス誘発抗腫瘍性銀（ｉ）配位錯体 Pending JP2008526873A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64280505P 2005-01-11 2005-01-11
US11/225,565 US8048870B2 (en) 2005-01-11 2005-09-13 Apoptosis-inducing antineoplastic silver (I) coordination complexes
PCT/US2006/000390 WO2006076216A2 (en) 2005-01-11 2006-01-05 Apoptosis-inducing antineoplastic silver (i) coordination complexes

Publications (2)

Publication Number Publication Date
JP2008526873A true JP2008526873A (ja) 2008-07-24
JP2008526873A5 JP2008526873A5 (https=) 2009-02-19

Family

ID=36654047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550477A Pending JP2008526873A (ja) 2005-01-11 2006-01-05 アポトーシス誘発抗腫瘍性銀（ｉ）配位錯体

Country Status (5)

Country Link
US (1) US8048870B2 (https=)
EP (1) EP1845997A4 (https=)
JP (1) JP2008526873A (https=)
CA (1) CA2593321A1 (https=)
WO (1) WO2006076216A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010505618A (ja) * 2006-10-13 2010-02-25 エージーエックスエックス インテレクチュアル プロパティー ホールディング ゲーエムベーハー ルテニウムを含有する生物活性コーティングおよびその装置

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2167097B1 (en) * 2007-05-31 2014-07-16 The University of Akron Metal complexes incorporated within biodegradable nanoparticles and their use
WO2009015112A2 (en) * 2007-07-23 2009-01-29 The University Of Akron Metal complexes incorporated within biodegradable nanoparticles and their use

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138167A (ja) * 1993-02-01 1995-05-30 Sangi Co Ltd 抗腫瘍剤及び抗菌剤
JP2002529411A (ja) * 1998-11-09 2002-09-10 ジェイ ニューマン，アイラ イオン性銀錯体
US20020136780A1 (en) * 2001-01-22 2002-09-26 Batarseh Kareem I. Microbicidal composition containing potassium sodium tartrate
JP2003519187A (ja) * 2000-01-06 2003-06-17 マランテック ホールディング リミテッド ライアビリティ カンパニー 癌管理のための電子活性化合物の使用方法
JP2003521472A (ja) * 1999-04-20 2003-07-15 バタルセ，カリーム 殺菌性製剤および微生物制御方法
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708864A (en) * 1984-12-14 1987-11-24 National Research Laboratories Method and compositions for treating dental structures
CH673225A5 (https=) * 1986-04-22 1990-02-28 Sanosil Ag
CA2070497C (en) * 1991-06-10 1999-05-25 Go Hata Novel platinum (ii) complex and antitumor agent
US5504055A (en) * 1994-03-15 1996-04-02 J.H. Biotech, Inc. Metal amino acid chelate
CA2285259A1 (en) * 1997-03-28 1998-10-08 The Scripps Research Institute Sandramycin analogs
US6280959B1 (en) * 1997-10-31 2001-08-28 Smithkline Beecham Corporation Metal complexes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138167A (ja) * 1993-02-01 1995-05-30 Sangi Co Ltd 抗腫瘍剤及び抗菌剤
JP2002529411A (ja) * 1998-11-09 2002-09-10 ジェイ ニューマン，アイラ イオン性銀錯体
JP2003521472A (ja) * 1999-04-20 2003-07-15 バタルセ，カリーム 殺菌性製剤および微生物制御方法
JP2003519187A (ja) * 2000-01-06 2003-06-17 マランテック ホールディング リミテッド ライアビリティ カンパニー 癌管理のための電子活性化合物の使用方法
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials
US20020136780A1 (en) * 2001-01-22 2002-09-26 Batarseh Kareem I. Microbicidal composition containing potassium sodium tartrate

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010505618A (ja) * 2006-10-13 2010-02-25 エージーエックスエックス インテレクチュアル プロパティー ホールディング ゲーエムベーハー ルテニウムを含有する生物活性コーティングおよびその装置
US9701848B2 (en) 2006-10-13 2017-07-11 Agxx Intellectual Property Holding Gmbh Bioactive, ruthenium-containing coating and device

Also Published As

Publication number Publication date
EP1845997A2 (en) 2007-10-24
US20060154911A1 (en) 2006-07-13
EP1845997A4 (en) 2009-12-30
WO2006076216A3 (en) 2007-09-13
WO2006076216A2 (en) 2006-07-20
US8048870B2 (en) 2011-11-01
CA2593321A1 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
Psomas et al. Quinolones and non-steroidal anti-inflammatory drugs interacting with copper (II), nickel (II), cobalt (II) and zinc (II): structural features, biological evaluation and perspectives
Abd-El-Aziz et al. Antimicrobial organometallic dendrimers with tunable activity against multidrug-resistant bacteria
Qi et al. Developing anticancer ferric prodrugs based on the N-donor residues of human serum albumin carrier IIA subdomain
Zhang et al. Developing a novel gold (III) agent to treat glioma based on the unique properties of apoferritin nanoparticles: inducing lethal autophagy and apoptosis
US12257225B2 (en) Polyoxometalate complexes and pharmaceutical compositions
Tolbatov et al. Diruthenium (II, III) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties
Hoffman-Luca et al. Syntheses, structures, and photochemistry of manganese nitrosyls derived from designed Schiff base ligands: potential NO donors that can be activated by near-infrared light
Di Santo et al. Biofilm inhibition by a new Mn (II) complex with sulfamethoxazole: Synthesis, spectroscopic characterization and crystal structure
EP4489865A2 (en) Combination therapies for modulation of lipid production
Medici et al. Noble metals in pharmaceuticals: Applications and limitations
Jadon et al. An integrative review of Cisplatin: the first metal anti-tumor drug.
Komyha et al. Design, structural characterization, molecular docking and biomedical applications of hydrazone-based Schiff base metal complexes
JP2008526873A (ja) アポトーシス誘発抗腫瘍性銀（ｉ）配位錯体
Batarseh Antineoplastic activities, apoptotic mechanism of action and structural properties of a novel silver (I) chelate
Arjmand et al. Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates
Darii et al. Crystalline multicomponent compounds involving hexaammine cobalt (iii) cations
Griffith et al. Novel platinum pyridinehydroxamic acid complexes: Synthesis, characterisation, X-ray crystallographic study and nitric oxide related properties
Kwon et al. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt (IV) compound, K104
EP1064264A1 (en) Cytotoxic metal chelators and methods for making and using same
JP2012531468A (ja) ３−ヒドロキシピリジン‐４−オンのフッ素化誘導体
JP6041811B2 (ja) 細菌由来の感染症を治療する抗細菌剤
Cao et al. α (N)-heterocyclic thiosemicarbazones: Iron chelators that are promising for revival of gallium in cancer chemotherapy
Ali et al. Can metal replacement increase the antitumor activity of azurin?(in vitro study)
ES2291120B2 (es) Sintesis y utilizacion del complejo ternario cu-fenantrolina-acido iodohipurico y compuestos relacionados como farmacos antitumorales.
CZ2012242A3 (cs) Pouzití komplexu medi obsahujících 2-fenyl-3-hydroxychinolin-4(1H)-on a deriváty 1,10-fenanthrolinu pro prípravu léciv pro lécbu nádorových onemocnení

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120507